Table 1

Assessment of asthma severity and change in cognitive function at study entry (baseline) and 5 year follow up (end point) in asthma patients with Alzheimer's disease

MMSE scoreAsthma symptom scoreDaily inhaler puffsNumber of hospital admissions for asthma
CaseAge (y)SexBaselineEnd pointBaselineEnd pointBaselineEnd pointBaselineEnd point
MMSE=Mini-Mental State Examination; SE=standard error.
*p<0.0001 (Wilcoxon rank test) compared with baseline data in all asthma patients with Alzheimer's disease; †p<0.0001; ‡p=0.0001; §p<0.0001 compared with baseline data in seven asthma patients with Alzheimer's disease (cases 1–7).
167M23186.41.21.3020
266M21168.62.21.4020
370F231710.21.62.4031
465M22157.81.22.61.430
565F21167.50.43.3120
669F23179.43.61.90.430
766F22169.22.42.2020
868M23217.67.42.82.632
Mean (SE)67.0 (0.7)22.3 (0.3)17.0 (0.7)*8.4 (0.5)1.8 (0.4)†2.2 (0.3)0.4 (0.2)‡2.4 (0.2)0.1 (0.1)§